Observational analysis reveals oncogenic circRNA CircFNIP1 may improve therapeutic strategies in lung cancer, suggesting new intervention pathways.
CircFNIP1 functions as an oncogenic circRNA in LC and represents a promising target for RNA-based therapeutic strategies. These findings provide a basis for the development of circFNIP1-targeted interventions in LC management.
No takes yet. Share an insight, caveat, or question.
Lan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: